CymaBay to Announce Third Quarter 2016 Financial Results on Wednesday, November 9
Nov 02, 2016 12:01 pm UTC| Business
NEWARK, Calif., Nov. 02, 2016 -- CymaBay Therapeutics, Inc. (NASDAQ:CBAY), a clinical-stage biopharmaceutical company focused on developing therapies to treat metabolic diseases with high unmet medical need, today...
Calithera Biosciences to Report Third Quarter 2016 Financial Results on Wednesday, November 9, 2016
Nov 02, 2016 12:01 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., Nov. 02, 2016 -- Calithera Biosciences, Inc. (Nasdaq:CALA), a clinical-stage pharmaceutical company focused on discovering and developing novel small molecule drugs directed against tumor...
Calithera Biosciences to Report Third Quarter 2016 Financial Results on Wednesday, November 9, 2016
Nov 02, 2016 12:01 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., Nov. 02, 2016 -- Calithera Biosciences, Inc. (Nasdaq:CALA), a clinical-stage pharmaceutical company focused on discovering and developing novel small molecule drugs directed against tumor...
Nov 02, 2016 12:01 pm UTC| Business
SEATTLE and SOUTH SAN FRANCISCO, Calif., Nov. 02, 2016 -- Immune Design (Nasdaq:IMDZ), a clinical-stage immunotherapy company focused on cancer, today announced that it will report third quarter 2016 financial results...
Nov 02, 2016 12:01 pm UTC| Business
SEATTLE and SOUTH SAN FRANCISCO, Calif., Nov. 02, 2016 -- Immune Design (Nasdaq:IMDZ), a clinical-stage immunotherapy company focused on cancer, today announced that it will report third quarter 2016 financial results...
Forward Pharma CFO to Participate in the Credit Suisse Annual Healthcare Conference in November
Nov 02, 2016 12:01 pm UTC| Business
COPENHAGEN, Denmark, Nov. 02, 2016 -- Forward Pharma A/S (FWP) (the “Company”), a biopharmaceutical company working to advance a proprietary formulation of DMF (dimethyl fumarate) for the treatment of inflammatory and...
Forward Pharma CFO to Participate in the Credit Suisse Annual Healthcare Conference in November
Nov 02, 2016 12:01 pm UTC| Business
COPENHAGEN, Denmark, Nov. 02, 2016 -- Forward Pharma A/S (FWP) (the “Company”), a biopharmaceutical company working to advance a proprietary formulation of DMF (dimethyl fumarate) for the treatment of inflammatory and...